Testing Integrative Smoking Cessation for HIV Patients
- Conditions
- SmokingSmoking CessationHIV Infections
- Interventions
- Behavioral: Mindfulness Training Smoking Cessation InterventionBehavioral: Contingency Management Smoking Cessation Intervention
- Registration Number
- NCT05030766
- Lead Sponsor
- University of Miami
- Brief Summary
The purpose of this study is to examine the feasibility, acceptability and effect of a combined smoking cessation intervention integrating contingency management (reward-based) strategies with Mindfulness training to identify the optimal dynamic strategy to promote smoking cessation among HIV patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 95
- Diagnosed with HIV (based on self-report).
- Be 18 years and older
- Have smoked ≥ 5 cigarettes/day in the past year
- Be interested in making a quit attempt in the next 30 days
- Own a smartphone (apple/android), and plan to keep it active for the next 6 months
- Able to consent
- Have no plans to move in the next 6 months
- Are not pregnant or planning to be pregnant in the following 6 months
- Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements
- Have contraindication to NRT (past month myocardial infarction, history of serious arrhythmias/or unstable angina pectoris, dermatological disorder)
- Are currently being treated for a psychiatric condition.
- Are currently being treated for smoking cessation, alcoholism, or illicit drug use
- Are adults unable to consent
- Are individuals who are not yet adults
- Are pregnant women
- Are prisoners
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description MT plus NRT Group-Phase 1 Nicotine Replacement Therapy Participants who receive the Mindfulness Training (MT) intervention for 4 weeks in addition to 6 weeks of Nicotine Replacement Therapy (NRT).These participants are responders (have quit smoking at the 1 month follow up) or non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive no additional intervention. MT plus NRT Group-Phase 1 Mindfulness Training Smoking Cessation Intervention Participants who receive the Mindfulness Training (MT) intervention for 4 weeks in addition to 6 weeks of Nicotine Replacement Therapy (NRT).These participants are responders (have quit smoking at the 1 month follow up) or non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive no additional intervention. CM plus NRT Group-Phase1 Nicotine Replacement Therapy Participants who receive the Contingency Management (CM) intervention for 4 weeks in addition to 6 weeks of NRT. These participants are responders (have quit smoking at the 1 month follow up) or non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive no additional intervention. CM plus NRT Group-Phase1 Contingency Management Smoking Cessation Intervention Participants who receive the Contingency Management (CM) intervention for 4 weeks in addition to 6 weeks of NRT. These participants are responders (have quit smoking at the 1 month follow up) or non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive no additional intervention. MT plus NRT with additional CM Group-Phase2 Nicotine Replacement Therapy Participants who received the MT intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional CM intervention for another 4 weeks. MT plus NRT with additional CM Group-Phase2 Mindfulness Training Smoking Cessation Intervention Participants who received the MT intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional CM intervention for another 4 weeks. MT plus NRT with additional CM Group-Phase2 Contingency Management Smoking Cessation Intervention Participants who received the MT intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional CM intervention for another 4 weeks. CM plus NRT with additional MT Group-Phase2 Nicotine Replacement Therapy Participants who received the CM intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional MT intervention for another 4 weeks. CM plus NRT with additional MT Group-Phase2 Mindfulness Training Smoking Cessation Intervention Participants who received the CM intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional MT intervention for another 4 weeks. CM plus NRT with additional MT Group-Phase2 Contingency Management Smoking Cessation Intervention Participants who received the CM intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional MT intervention for another 4 weeks.
- Primary Outcome Measures
Name Time Method Number of Participants Reporting 7-day Point-prevalence Abstinence 4 weeks (end of treatment), and 3 months Defined as self-report of not smoking in the past 7-days, not even a puff and confirmed by expired carbon monoxide (CO) level cutoff of \< 8 ppm using a coVita iCO™ Smokerlyzer® and/or NicoTests saliva sample of ≤ 30 ng/mL.
- Secondary Outcome Measures
Name Time Method Retention Rate 3 months Treatment specific retention rates reported as the percentage of participants who completed their final 3-month assessment divided by the total of participants enrolled.
Treatment Specific Adherence Rates 3 months Defined as number of phone-call check-ins attended by each participant (4 for mindfulness training, 12 for contingency management).
Trial Locations
- Locations (1)
University of Miami
🇺🇸Miami, Florida, United States
University of Miami🇺🇸Miami, Florida, United States